|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ohgaki H and Kleihues P: Genetic pathways
to primary and secondary glioblastoma. Am J Pathol. 170:1445–1453.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Baumert BG, Hegi ME, Van den Bent MJ, von
Deimling A, Gorlia T, Hoang-Xuan K, Brandes AA, Kantor G, Taphoorn
MJ, Hassel MB, et al: Temozolomide chemotherapy versus radiotherapy
in high-risk low-grade glioma (EORTC 22033–26033): A randomised,
open-label, phase 3 intergroup study. Lancet Oncol. 17:1521–1532.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Norden AD, Drappatz J and Wen PY: Novel
anti-angiogenic therapies for malignant gliomas. Lancet Neurol.
7:1152–1160. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Belotserkovskaya R, Oh S, Bondarenko VA,
Orphanides G, Studitsky VM and Reinberg D: FACT facilitates
transcription-dependent nucleosome alteration. Science.
301:1090–1093. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Röttgers K, Krohn NM, Lichota J, Stemmer
C, Merkle T and Grasser KD: DNA-interactions and nuclear
localisation of the chromosomal HMG domain protein SSRP1 from
maize. Plant J. 23:395–405. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Birch JL, Tan BC, Panov KI, Panova TB,
Andersen JS, Owen-Hughes TA, Russell J, Lee SC and Zomerdijk JC:
FACT facilitates chromatin transcription by RNA polymerases I and
III. EMBO J. 28:854–865. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kumari A, Mazina OM, Shinde U, Mazin AV
and Lu H: A role for SSRP1 in recombination-mediated DNA damage
response. J Cell Biochem. 108:508–518. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mason PB and Struhl K: The FACT complex
travels with elongating RNA polymerase II and is important for the
fidelity of transcriptional initiation in vivo. Mol Cell Biol.
23:8323–8333. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tan BC, Liu H, Lin CL and Lee SC:
Functional cooperation between FACT and MCM is coordinated with
cell cycle and differential complex formation. J Biomed Sci.
17:112010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang W, Zeng F, Liu Y, Shao C, Li S, Lv
H, Shi Y, Niu L, Teng M and Li X: Crystal structure of human SSRP1
middle domain reveals a role in DNA binding. Sci Rep. 5:186882015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Garcia H, Fleyshman D, Kolesnikova K,
Safina A, Commane M, Paszkiewicz G, Omelian A, Morrison C and
Gurova K: Expression of FACT in mammalian tissues suggests its role
in maintaining of undifferentiated state of cells. Oncotarget.
2:783–796. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Garcia H, Miecznikowski JC, Safina A,
Commane M, Ruusulehto A, Kilpinen S, Leach RW, Attwood K, Li Y,
Degan S, et al: Facilitates chromatin transcription complex is an
‘accelerator’ of tumor transformation and potential marker and
target of aggressive cancers. Cell Reports. 4:159–173. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ding Q, He K, Luo T, Deng Y, Wang H, Liu
H, Zhang J, Chen K, Xiao J, Duan X, et al: SSRP1 contributes to the
malignancy of hepatocellular carcinoma and is negatively regulated
by miR-497. Mol Ther. 24:903–914. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dermawan JK, Gurova K, Pink J, Dowlati A,
De S, Narla G, Sharma N and Stark GR: Quinacrine overcomes
resistance to erlotinib by inhibiting FACT, NF-κB, and cell-cycle
progression in non-small cell lung cancer. Mol Cancer Ther.
13:2203–2214. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Koman IE, Commane M, Paszkiewicz G,
Hoonjan B, Pal S, Safina A, Toshkov I, Purmal AA, Wang D, Liu S, et
al: Targeting FACT complex suppresses mammary tumorigenesis in
Her2/neu transgenic mice. Cancer Prev Res. 5:1025–1035. 2012.
View Article : Google Scholar
|
|
17
|
Carter DR, Murray J, Cheung BB, Gamble L,
Koach J, Tsang J, Sutton S, Kalla H, Syed S, Gifford AJ, et al:
Therapeutic targeting of the MYC signal by inhibition of histone
chaperone FACT in neuroblastoma. Sci Transl Med. 7:312ra1762015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lake D, Corrêa SA and Müller J: Negative
feedback regulation of the ERK1/2 MAPK pathway. Cell Mol Life Sci.
73:4397–4413. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Z, Guo Q, Wang R, Xu G, Li P, Sun Y,
She X, Liu Q, Chen Q, Yu Z, et al: The D Domain of LRRC4 anchors
ERK1/2 in the cytoplasm and competitively inhibits MEK/ERK
activation in glioma cells. J Hematol Oncol. 9:1302016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shingu T, Holmes L, Henry V, Wang Q, Latha
K, Gururaj AE, Gibson LA, Doucette T, Lang FF, Rao G, et al:
Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor
tyrosine kinase inhibitors in glioma tumor-initiating cells. J
Transl Med. 14:462016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Takahata S, Yu Y and Stillman DJ: FACT and
Asf1 regulate nucleosome dynamics and coactivator binding at the HO
promoter. Mol Cell. 34:405–415. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tsunaka Y, Fujiwara Y, Oyama T, Hirose S
and Morikawa K: Integrated molecular mechanism directing nucleosome
reorganization by human FACT. Genes Dev. 30:673–686. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gao XJ, Feng JX, Zhu S, Liu XH, Tardieux I
and Liu LX: Protein phosphatase 2C of toxoplasma gondii interacts
with human SSRP1 and negatively regulates cell apoptosis. Biomed
Environ Sci. 27:883–893. 2014.PubMed/NCBI
|
|
24
|
Furnari FB, Fenton T, Bachoo RM, Mukasa A,
Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, et al:
Malignant astrocytic glioma: Genetics, biology, and paths to
treatment. Genes Dev. 21:2683–2710. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Raman M, Chen W and Cobb MH: Differential
regulation and properties of MAPKs. Oncogene. 26:3100–3112. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Owens DM and Keyse SM: Differential
regulation of MAP kinase signalling by dual-specificity protein
phosphatases. Oncogene. 26:3203–3213. 2007. View Article : Google Scholar : PubMed/NCBI
|
